Bioanalytical Systems announced the company broke ground last week on the expansion of its GLP toxicology facility on its 52-acre campus in Mt. Vernon, Indiana.
Set to open by the end of 2019, the expansion effort will more than double the facility’s current capacity for the development of protein-based therapeutics.
“It’s really exciting to see shovels hit the dirt bringing us closer to this much-anticipated, state-of-the-art expansion,” said Philip Downing, senior vice president of preclinical services at BASi. “This upgrade, coupled with improvements we have made during 2018 to our environmental systems and infrastructure, allows us to add the needed capacity to grow the business and meet the needs of our clients, which is paramount, while contributing to the important advancements in research that drive our industry.”
To meet the demands of the growing market, the company is already in the planning phases for further expansion and added capacity moving into 2020.